Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.49147 | 57 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.38133 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.39403 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.40444 | 57 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.30862 | 55 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.55449 | 57 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.51413 | 56 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.36864 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.35754 | 55 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.31507 | 54 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.38128 | 55 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.36021 | 56 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.41595 | 56 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.37167 | 55 |